--- title: 'Director, Clinical Contracts at Vir Biotechnology' canonical: 'https://feeny.ai/job/director-clinical-contracts-vir-biotechnology-san-francisco-ann0130xxcqz' type: 'job' last_seen: '2026-10-17' --- # Director, Clinical Contracts at Vir Biotechnology - **Company:** Vir Biotechnology - **Location:** San Francisco, CA - **Posted:** 2026-10-12 - **Last confirmed live:** 2026-10-17 - **Apply:** https://job-boards.greenhouse.io/virbiotechnologyinc/jobs/4742944005 ## Job description Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Vir Biotechnology has exclusive rights to the universal PRO-XTEN® masking platform for oncology and infectious disease. PRO-XTEN® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company. We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best. ## THE OPPORTUNITY Vir Biotechnology is seeking a Director, Clinical Contracts-Transactional Counsel to lead the execution of clinical contracting activities supporting our global development programs. Reporting to the Vice President, Strategic Transactions, this role will serve as the primary legal and business partner for clinical contracting matters across clinical trial sites and external vendors. This is a hands-on position responsible for personally managing the drafting, review, negotiation, and execution of a broad range of clinical agreements. The successful candidate will combine deep clinical contracting expertise with practical business judgment to support efficient study startup and execution while appropriately managing risk. This role is based in our San Francisco headquarters with an expectation of 3 days per week in the office. ## WHAT YOU'LL DO - Lead and conduct negotiations of clinical study agreements, including clinical trial agreements, confidentiality agreements, amendments, informed consent-related documents, and other site-facing agreements - Draft, review, negotiate, and manage vendor contracts, including master service agreements, statements of work, material transfer agreements, consulting agreements, and other development-related agreements - Own the end-to-end clinical contracting process for global, multi-site clinical trials, ensuring timely execution in support of development milestones - Serve as the primary contracting partner to Clinical Operations, Clinical Development, Procurement, Finance, and Legal teams - Provide practical, risk-based guidance on contractual issues and drive resolution of negotiation escalations - Own and continuously enhance clinical contracting templates, negotiation playbooks, and standard agreement language, incorporating lessons learned from negotiations, evolving regulatory requirements, and industry best practices - Partner closely with internal stakeholders to identify contracting risks, develop solutions, and ensure agreement terms support operational execution - Oversee day-to-day management of external site contracting and budget vendors, including governance meetings, KPI reviews, and service work order execution - Monitor changes in applicable regulations and industry practices and incorporate updates into contracting processes and templates - Drive continuous improvement of clinical contracting processes, templates, and negotiation playbooks to enhance efficiency, consistency, and scalability across Vir's global clinical portfolio ## WHO YOU ARE AND WHAT YOU BRING - JD and 10+ years of experience in the pharmaceutical, biotechnology, or life sciences industry, with significant experience negotiating clinical trial agreements and related development contracts - Deep expertise independently drafting, reviewing, negotiating, and managing a high volume of clinical trial and vendor agreements - Demonstrated experience supporting global clinical development programs across multiple countries and regions - Strong understanding of clinical research regulations and country-specific contracting requirements - Ability to balance legal risk with business and operational priorities while providing practical, solution-oriented guidance - Experience collaborating with Clinical Operations, Development, Legal, Procurement, and Finance stakeholders in a fast-paced environment - Knowledge of outsourcing models, vendor governance, procurement processes, and contract execution workflows - Excellent negotiation, communication, project management, and stakeholder management skills - Proven ability to independently manage a complex and diverse portfolio of contracting activities with minimal supervision ## #LI-AS1 #LI-Onsite ## WHO WE ARE AND WHAT WE OFFER The expected salary range for this position is $1203,500 to $284,000 per year. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors. Vir Biotechnology's compensation and benefits are aligned with the current market and commensurate with the person’s experience and qualifications. All full-time employees receive a package that includes compensation, bonus and equity as well as many other Vir Biotechnology benefits and perks such as health and welfare benefit plans, non-accrual paid time off, company shut down for holidays, commuter benefits, 401K match and lunch each day in the office. Applicants must currently be authorized to work for any employer in the U.S.  We are unable to sponsor or take over sponsorship of an employment Visa at this time. All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made without regard to any legally protected characteristics. This commitment extends to all management practices and decisions, including recruitment and hiring, compensation, appraisal systems, promotions, training and career development programs.  Vir Biotechnology also strongly commits to providing employees with a work environment free of unlawful conduct or harassment. Vir Biotechnology Human Resources leads recruitment and employment for Vir Biotechnology. Unsolicited resumes sent to the company from recruiters do not constitute any type of relationship between the recruiter and Vir Biotechnology and do not obligate us to pay fees should we hire from those resumes. We ask that external recruiters and/or agencies not contact or present candidates directly to our hiring manager or employees. For hires based in the United States, Vir Biotechnology, participates in [E-Verify](https://www.e-verify.gov/sites/default/files/everify/posters/EVerifyParticipationPoster.pdf). [Candidate Privacy Notice](https://www.vir.bio/candidate-notice/) ## About Vir Biotechnology ## Company Overview - **One-liner**: Vir Biotechnology is a clinical-stage immunology company focused on engineering powerful antibody-based medicines to treat infectious diseases and cancer. - **Entity Type**: Public (Ticker: VIR) - **Headquarters**: San Francisco, California, United States - **Founded**: 2016 - **Founders**: Not publicly available (the company was formed with founding investments from ARCH Venture Partners, the Bill & Melinda Gates Foundation, and others) ## Core Business - **Primary Industry**: Biotechnology (Immunology, Infectious Disease, Oncology) - **Target Customers**: Patients with serious infectious diseases (e.g., chronic hepatitis delta, COVID-19, Ebola) and specific cancers; the company's customers are effectively patients and healthcare systems, with revenue coming from partnerships and product sales. - **Mission/Purpose**: "Power the immune system to transform lives" by delivering potentially transformative medicines for patients with high unmet medical needs. ## Products & Services - **Next-Generation Antibody Platform**: A proprietary platform that enables the rapid discovery, optimization, and advancement of antibody candidates for infectious diseases. - **PRO-XTEN® Protease-Releasable Masking Technology**: A platform (exclusive rights for oncology and infectious disease) used to engineer conditionally activated antibodies that are designed to be safer and more effective in treating cancer. PRO-XTEN® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company. - **Pipeline Programs**: The company’s pipeline includes leading programs in chronic hepatitis delta virus (HDV) and strategically expanding into oncology. They have demonstrated their ability to discover and develop antibody-based medicines for COVID-19 and Ebola. ## Market Standing - **Valuation/Market Cap**: Market cap fluctuates with stock price. As of recent reporting, it is in the range of several billion USD. For the most current figure, refer to financial data providers. - **Key Metric**: As a public company, key metrics include R&D spending, cash position, and pipeline progress. The company had significant revenue from its COVID-19 antibody partnership (sotrovimab) but is now focused on advancing its pipeline. - **Notable Investors/Partners**: Founding investors include ARCH Venture Partners and the Bill & Melinda Gates Foundation. Key partners include Alnylam Pharmaceuticals and Sanofi (via the Amunix/PRO-XTEN platform). - **Growth Signals**: The company is actively expanding its oncology pipeline, appointing an SVP of Oncology and a Vice President of Clinical Research-Oncology. It continues to hire across R&D, regulatory, and business development, signaling a phase of growth and pipeline advancement. ## Competitive Advantages - **Deep Immunology Expertise**: The company has a world-class team with deep knowledge of immunology and antibody engineering. - **Dual-Platform Strategy**: Combining a powerful antibody discovery platform with the PRO-XTEN® masking technology gives it a unique ability to create both potent and safer therapies. - **Proven Track Record**: Successfully developed and brought to market a COVID-19 antibody (sotrovimab) and an Ebola treatment (mAb114) on an accelerated timeline, demonstrating execution capability. - **Focus on Unmet Needs**: Concentrates on diseases with limited treatment options, such as chronic hepatitis delta and hard-to-treat cancers. ## Strategic Focus - **Infectious Disease Foundation**: Continuing to advance its core programs in infectious diseases, with a leading program in chronic hepatitis delta. - **Strategic Oncology Expansion**: Building a robust oncology pipeline using its antibody and PRO-XTEN® platforms, with a focus on indications with high unmet need. - **Pipeline Acceleration**: Leveraging its platforms to rapidly identify, optimize, and advance candidates from concept to clinic. - **Building for the Long Term**: The company is strategically building its capabilities and team to become a multi-product, multi-indication biotech. ## Why Work Here - **Mission-Driven**: Employees are directly contributing to developing transformative medicines for patients with serious diseases. - **World-Class Team**: Opportunity to work alongside industry-leading scientists, clinicians, and business leaders in the U.S. and Europe. - **Commitment to Fair Pay**: The company has an "unwavering commitment to fair pay" with a rigorous, proactive approach to compensation based on skills and experience. U.S. salary ranges are shared internally for transparency. - **Generous Benefits**: Includes health benefits and wellness program, unaccrued time off with structured holidays, on-site paid parking, lunch, and transit spending account (in the U.S.). - **Workplace Culture**: The company emphasizes "Virtues" over values and a culture of urgency and impact. - **Locations**: Primarily San Francisco, CA, with some remote options for specific roles (e.g., Regulatory Writer). European offices are also part of the company. ## Sources 1. [vir.bio](https://www.vir.bio/) 2. [vir.bio/careers](https://www.vir.bio/careers/) 3. [job-boards.greenhouse.io/virbiotechnologyinc](http://job-boards.greenhouse.io/virbiotechnologyinc) 4. [vir.bio/about/strategy](https://www.vir.bio/about/strategy/) ## Other roles at Vir Biotechnology - [Senior Director, Head of Clinical Pharmacology](https://feeny.ai/job/senior-director-head-of-clinical-pharmacology-vir-biotechnology-united-states-3rhq3yhvnnf1) — United States - [SVP, Regulatory Affairs](https://feeny.ai/job/svp-regulatory-affairs-vir-biotechnology-san-francisco-q3eswvctgp3v) — San Francisco, CA - [Senior Director, Total Rewards and HRIS](https://feeny.ai/job/senior-director-total-rewards-and-hris-vir-biotechnology-san-francisco-cbww9w8dee7n) — San Francisco, CA - [Senior Director, Clinical Research-Program Executive-Oncology](https://feeny.ai/job/senior-director-clinical-research-program-executive-oncology-vir-biotechnology-r41tr7w00x99) — San Francisco, CA - [Director, Clinical Operations](https://feeny.ai/job/director-clinical-operations-vir-biotechnology-san-francisco-ajxvfttp1cq5) — San Francisco, CA - [Associate Director, Clinical Scientist](https://feeny.ai/job/associate-director-clinical-scientist-vir-biotechnology-san-francisco-kz6ttfjzvf2m) — San Francisco, CA - [Associate Director, CMC Project Management](https://feeny.ai/job/associate-director-cmc-project-management-vir-biotechnology-san-francisco-rgwkehm4691f) — San Francisco, CA - [Associate Director, Quality Systems (Temporary)](https://feeny.ai/job/associate-director-quality-systems-temporary-vir-biotechnology-san-francisco-x0xjcec1q94g) — San Francisco, CA - [Senior Specialist, QA Operations (Temporary)](https://feeny.ai/job/senior-specialist-qa-operations-temporary-vir-biotechnology-san-francisco-mjvvaa0hjtne) — San Francisco, CA - [Senior Scientist I, Drug Product & Device Development (Temporary)](https://feeny.ai/job/senior-scientist-i-drug-product-device-development-temporary-vir-biotechnology-yxcegjgez7qk) — San Francisco, CA